Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma

Yildiz, Hanifi; Alp, Hamit; Sünnetçioğlu, A; Ekin, Selami; Mermit, Buket

doi:10.1016/j.hrtlng.2020.04.017

Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma

Yildiz H., Alp H. H., Sünnetçioğlu A., Ekin S., Mermit Ç.

HEART & LUNG, vol.50, no.1, pp.177-183, 2021 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 50 Issue: 1
Publication Date: 2021
Doi Number: 10.1016/j.hrtlng.2020.04.017
Journal Name: HEART & LUNG
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Page Numbers: pp.177-183
Keywords: Asthma, exacerbation, periostin, YKL-40, IL-37, cytokines, ALLERGIC AIRWAY INFLAMMATION, NECROSIS-FACTOR-ALPHA, TNF-ALPHA, LUNG, IL-18R-ALPHA, BIOMARKERS, DIAGNOSIS, PHENOTYPE, SEVERITY, MARKERS
Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Introduction: As asthma has a wide range of inflammatory pathways, the researchers were focused on the markers that may be associated with exacerbation and stability in asthma.